Jounce Therapeutics Inc (JNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | JNCE | ZTS | TAK | GRFS | NBIX |
| Company | Jounce Therapeutics Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Grifols S.A. ADR | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 1.9200 | 146.25 | 13.37 | 6.49 | 141.00 |
| High | 1.9300 | 149.90 | 13.41 | 6.66 | 145.00 |
| Low | 1.8800 | 145.18 | 13.30 | 6.43 | 139.26 |
| Last | 1.8800 | 149.64 | 13.40 | 6.44 | 140.06 |
| Change | -0.0500 | +4.10 | +0.04 | +0.14 | +6.40 |
| % Change | -2.59% | +2.82% | +0.30% | +2.22% | +4.79% |
| Volume | 11,600,600 | 1,864,842 | 851,913 | 1,245,597 | 709,216 |
| 20-Day Average Volume | 1,541,820 | 4,024,026 | 1,770,136 | 1,269,252 | 750,681 |
| Previous Close | 1.9300 | 145.54 | 13.36 | 6.30 | 133.66 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.9078 | 159.39 | 13.54 | 6.71 | 136.68 |
| 20-Day Raw Stochastic | 16.67% | 17.43% | 20.52% | 19.55% | 67.72% |
| 20-Day Relative Strength | 62.73% | 32.39% | 39.22% | 44.61% | 56.12% |
| Weighted Alpha | -65.90 | -21.13 | -19.38 | -0.75 | +41.35 |
| Today's Opinion | 24% Buy | 88% Sell | 100% Sell | 100% Sell | 96% Buy |
| Previous Opinion | 40% Buy | 88% Sell | 100% Sell | 100% Sell | 56% Buy |
| Last Month's Opinion | 24% Buy | 24% Sell | 56% Sell | 100% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.59% since 04/26/23 | -2.37% since 04/16/24 | +1.17% since 04/16/24 | -4.65% since 04/16/24 | +5.42% since 04/16/24 |
| Low | 1.8800 on 05/03/23 | 144.80 on 04/22/24 | 13.11 on 04/17/24 | 6.25 on 04/22/24 | 130.13 on 04/19/24 |
| High | 1.9500 on 04/28/23 | 153.67 on 04/18/24 | 13.41 on 04/22/24 | 6.84 on 04/17/24 | 145.00 on 04/23/24 |
| 1-Month | |||||
| %Chg | +1.62% since 04/03/23 | -11.55% since 03/22/24 | -7.11% since 03/22/24 | +3.94% since 03/22/24 | -0.87% since 03/22/24 |
| Low | 1.8400 on 04/04/23 | 144.80 on 04/22/24 | 13.11 on 04/17/24 | 6.25 on 04/22/24 | 130.13 on 04/19/24 |
| High | 1.9800 on 04/17/23 | 171.14 on 03/28/24 | 14.45 on 03/26/24 | 7.35 on 04/09/24 | 145.00 on 04/23/24 |
| 3-Month | |||||
| %Chg | +55.37% since 02/03/23 | -20.58% since 01/23/24 | -9.13% since 01/23/24 | -12.04% since 01/23/24 | -0.15% since 01/23/24 |
| Low | 0.8957 on 03/10/23 | 144.80 on 04/22/24 | 13.11 on 04/17/24 | 5.30 on 03/06/24 | 128.00 on 02/07/24 |
| High | 1.9800 on 04/17/23 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 9.37 on 02/28/24 | 148.37 on 03/21/24 |
| 6-Month | |||||
| %Chg | -10.48% since 11/03/22 | -10.28% since 10/23/23 | -7.82% since 10/23/23 | -18.27% since 10/23/23 | +29.92% since 10/23/23 |
| Low | 0.5773 on 12/13/22 | 144.80 on 04/22/24 | 13.11 on 04/17/24 | 5.30 on 03/06/24 | 103.63 on 11/10/23 |
| High | 2.1180 on 11/09/22 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 12.15 on 12/29/23 | 148.37 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 98,954 | 66,564,024 | 42,281,968 | 4,331,628 | 13,300,106 |
| Shares Outstanding, K | 52,635 | 457,359 | 3,164,818 | 687,560 | 99,507 |
| Annual Sales | 82,000,000 | 8,544,000,000 | 29,803,340,000 | 7,134,500,000 | 1,887,100,000 |
| Annual Net Income | -50,920,000 | 2,344,000,000 | 2,345,930,000 | 131,340,000 | 249,700,000 |
| Last Quarter Sales | 82,000,000 | 2,213,000,000 | 7,556,070,000 | 2,025,030,000 | 515,200,000 |
| Last Quarter Net Income | 50,960,000 | 525,000,000 | 718,900,000 | 125,920,000 | 147,700,000 |
| 60-Month Beta | 0.75 | 0.85 | 0.53 | 0.56 | 0.25 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.60 on 11/10/22 | 1.24 on 02/13/24 | 0.51 on 02/01/24 | 0.09 on 07/27/23 | 1.44 on 02/07/24 |
| Latest Earnings Date | 05/04/23 | 05/02/24 | 05/09/24 | 03/05/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | 0.370 on 06/03/21 | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | 06/03/21 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 27.54 | 6.79 | 0.00 | 54.55 |